These drugs function by inhibiting the activity of VEGF, a pivotal factor in angiogenesis and vascular permeability, thereby reducing macular edema and enhancing visual acuity for patients with these conditions [35,38,37]. This evidence concerns the gene VEGFA and macular retinal edema.